In the EORP-AF Pilot registry on the prognosis and treatment of patients with atrial fibrillation (AF), 1-year mortality is high. Symptoms are still common in patients with AF, and hospital readmissions are mainly owing to AF and heart failure. Oral anticoagulation use has increased, but a rhythm-control strategy is uncommon.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lip, G. Y. et al. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational research programme—atrial fibrillation general registry pilot phase (EORP-AF Pilot registry). Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehu374.
Nieuwlaat, R. et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on atrial fibrillation. Eur. Heart J. 26, 2422–2434 (2005).
Krijthe, B. P. et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur. Heart J. 35, 2746–2751 (2013).
Camm, A. J. et al. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur. Heart J. 31, 2369–2429 (2010).
Camm, A. J. et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation. An update of the 2010 ESC guidelines for the management of atrial fibrillation. Eur. Heart J. 33, 2719–2747 (2012).
De Caterina, R. et al. Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. Heart 100, 1625–1635 (2014).
Lamberts, M. et al. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation 129, 1577–1585 (2014).
Steinberg, B. A. et al. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry. Circulation 128, 721–728 (2013).
Piccini, J. P. et al. Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur. Heart J. 35, 250–256 (2014).
Andersson, T. et al. All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study. Eur. Heart J. 34, 1061–1067 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Scherr, D., Jais, P. AF prognosis and treatment—the European perspective. Nat Rev Cardiol 11, 689–690 (2014). https://doi.org/10.1038/nrcardio.2014.171
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2014.171
